ArticlePLoS pathogens2025
Sclerotinia sclerotiorum growth and aggressiveness are regulated by a mycoviral REP protein.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The mechanisms through which mycoviruses reduce fungal growth and aggressiveness remain unclear, particularly regarding the viral factors involved and their modes of action. In this work, we investigated the hypovirulence mechanism by which Sclerotinia sclerotiorum hypovirulence-associated DNA virus 1 (SsHADV1), of the species Gemycircularvirus sclero1, impaired the necrotrophic plant fungus Sclerotinia sclerotiorum growth. We first identified the replication-associated protein (REP) of SsHADV1 as the key factor of hypovirulence. Using different patho-systems, we demonstrated that the viral SsHADV1 REP outside the context of viral infection directly restricts fungal growth and disease development. This slow growth was associated with a reduction in fungal oxalic acid production, which is an essential factor for fungal pathogenicity, and with an increase in fungal susceptibility to sublethal concentration of commercial fungicide. Additionally, the exogenous application of SsHADV1 REP protected sunflower plants from basal stem rot by S. sclerotiorum. In tobacco plants, the overexpression of SsHADV1 REP primes plant stress-related and immune responses, likely enhancing the hypovirulence activity against S. sclerotiorum. Hypovirulence was replicated using the REP of an unrelated ssDNA virus of S. sclerotiorum despite their overall low sequence identity. This conserved function of REP is structurally dependent and requires a functional ATPase domain. This study provides the first molecular insight on the mode of action of an hypovirulent mycovirus. It further establishes the ecological role of mycoviruses and their encoded proteins as potential drivers of fungal disease outcome and severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.